Lv1
90 积分 2022-09-12 加入
Additive efficacy of a bispecific anti–TNF/IL-6 nanobody compound in translational models of rheumatoid arthritis
13天前
已完结
Solution Structures of Human Parathyroid Hormone Fragments hPTH(1–34) and hPTH(1–39) and Bovine Parathyroid Hormone Fragment bPTH(1–37)
14天前
已完结
Principles of antibodies with ultralong complementarity-determining regions and picobodies
1个月前
已完结
Synergistic activation of the insulin receptor via two distinct sites
1个月前
已完结
Disulfide linkage engineering for improving biophysical properties of human VH domains
1个月前
已完结
VH/VL interface engineering to promote selective expression and inhibit conformational isomerization of thrombopoietin receptor agonist single-chain diabody
2个月前
已完结
The Solution Structure of Melanoma Growth Stimulating Activity
2个月前
已完结
Topological Requirements and Signaling Properties of T Cell–activating, Anti-CD28 Antibody Superagonists
2个月前
已完结
The Emergence of a New Paradigm with Signal 1 and Signal 2 T-cell Engagers in Hematology
2个月前
已关闭
A CD38/CD3xCD28 trispecific T‐cell engager as a potentially active agent in multiple myeloma patients relapsed and/or refractory to anti‐CD38 monoclonal antibodies
3个月前
已完结
皖公网安备34019202002308
